{"id":1387,"date":"2015-11-12T16:43:31","date_gmt":"2015-11-12T16:43:31","guid":{"rendered":"http:\/\/www.imperialcrs.com\/blog\/?p=1387"},"modified":"2023-12-14T15:01:19","modified_gmt":"2023-12-14T15:01:19","slug":"talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west","status":"publish","type":"post","link":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/","title":{"rendered":"Talking Recruitment with Small\/Mid BioPharm CMOs at CMO Summit &#8211; West"},"content":{"rendered":"<p>I had the honor of attending and presenting at the <strong><a href=\"https:\/\/theconferenceforum.org\/conferences\/cmo-summit-west\/overview\/\" target=\"_blank\" rel=\"noopener\">CMO Summit &#8211; West<\/a><\/strong> earlier this week in Burlingame, CA. Attended by 75-80 industry executives &#8211; primarily consisting of Chief Medical Officers, heads of clinical development and leaders from the financial community &#8211; the CMO Summit is an intimate and dynamic forum for discussion of the challenges facing today&#8217;s medical leaders from small to mid size bio-pharmaceutical companies.<\/p>\n<p>My presentation focused on the current trends in patient recruitment impacting today&#8217;s CMOs and specifically, how these individuals are addressing the challenge of on time enrollment in their clinical trials. In fact, there is probably no group that I have worked with over the years who are under more pressure than the CMO from a small\/mid-sized sponsor, who is working under a VC backed financing structure.<\/p>\n<p>Yet, despite many of the investments in these firms being heavily time and cost milestone driven, we still see <strong>too many of these decision makers being reluctant to implement proactive patient recruitment campaigns<\/strong>. The result often being delayed trials, significant budgetary impact and a boatload of stress.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" aligncenter\" src=\"https:\/\/media.licdn.com\/mpr\/mpr\/jc\/AAEAAQAAAAAAAAPqAAAAJDAzYmUzOTI4LWQzYTQtNDAwZS1hYjgwLTQ3Y2Y5NjYwODhiMA.png\" alt=\"\" width=\"931\" height=\"533\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>Certainly, over my 16 years in patient recruitment, I have seen a sea-change in the mindset of sponsors when it comes to recruitment. In fact, when I first started out, about 80% of the programs I worked on were rescue\/reactive type situations. <strong>Today, more than 60% of the recruitment programs are proactiv<\/strong><strong>e<\/strong>. This is major progress, but it&#8217;s been far too slow.<\/p>\n<p>DAC has analyzed the behavior of CMOs and C-teams from small\/mid sponsors who meet their enrollment timelines. We have also compared the cost differences between proactive recruitment programs and reactive ones.<\/p>\n<p>My presentation at the CMO Summit- West covered these issues and more. Please let me know if you are interested in receiving a copy of the slides. For CMOs and C-Suite teams at small\/mid sponsors, I would welcome the opportunity to schedule a web-conference and present the same material to you. <strong><a href=\"mailto: dmcdonald@dacprs.com\">Just shoot me a message<\/a><\/strong> with your availability.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>I had the honor of attending and presenting at the CMO Summit &#8211; West earlier this week in Burlingame, CA. Attended by 75-80 industry executives &#8211; primarily consisting of Chief Medical Officers, heads of clinical development and leaders from the financial community &#8211; the CMO&hellip;<\/p>\n","protected":false},"author":7,"featured_media":69665,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[43,35],"tags":[1761,1765,1767,1769,1762,1766,1768,1764,958,1763],"class_list":["post-1387","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events","category-patient-recruitment-and-retention","tag-biopharmaceutical-recruitment-strategies","tag-clinical-development-insights","tag-clinical-operations-challenges","tag-clinical-research-management","tag-clinical-trial-cmo-summit","tag-cmo-summit-discussions","tag-drug-development-planning","tag-midsize-biopharma-cmos","tag-patient-recruitment-solutions","tag-small-biopharmaceutical-companies"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Talking Recruitment with CMOs<\/title>\n<meta name=\"description\" content=\"current trends in patient recruitment impacting CMOs and how these individuals are addressing the challenge of ontime enrollment in their clinical trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Talking Recruitment with CMOs\" \/>\n<meta property=\"og:description\" content=\"current trends in patient recruitment impacting CMOs and how these individuals are addressing the challenge of ontime enrollment in their clinical trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/\" \/>\n<meta property=\"og:site_name\" content=\"Imperial Clinical Research Services Blog\" \/>\n<meta property=\"article:published_time\" content=\"2015-11-12T16:43:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-14T15:01:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/11\/Current-trends-in-patient-recruitment.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dan McDonald\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dan McDonald\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/\"},\"author\":{\"name\":\"Dan McDonald\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/b51d07a38b5a99e1182dd1918173a2da\"},\"headline\":\"Talking Recruitment with Small\\\/Mid BioPharm CMOs at CMO Summit &#8211; West\",\"datePublished\":\"2015-11-12T16:43:31+00:00\",\"dateModified\":\"2023-12-14T15:01:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/\"},\"wordCount\":351,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/Current-trends-in-patient-recruitment.jpg\",\"keywords\":[\"Biopharmaceutical Recruitment Strategies\",\"Clinical Development Insights\",\"Clinical Operations Challenges\",\"Clinical Research Management\",\"Clinical Trial CMO Summit\",\"CMO Summit Discussions\",\"Drug Development Planning\",\"Midsize BioPharma CMOs\",\"Patient Recruitment Solutions\",\"Small Biopharmaceutical Companies\"],\"articleSection\":[\"Life-Science Events\",\"Patient Recruitment and Retention\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/\",\"name\":\"Talking Recruitment with CMOs\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/Current-trends-in-patient-recruitment.jpg\",\"datePublished\":\"2015-11-12T16:43:31+00:00\",\"dateModified\":\"2023-12-14T15:01:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/b51d07a38b5a99e1182dd1918173a2da\"},\"description\":\"current trends in patient recruitment impacting CMOs and how these individuals are addressing the challenge of ontime enrollment in their clinical trials.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/Current-trends-in-patient-recruitment.jpg\",\"contentUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/Current-trends-in-patient-recruitment.jpg\",\"width\":800,\"height\":533},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/patient-recruitment-and-retention\\\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Talking Recruitment with Small\\\/Mid BioPharm CMOs at CMO Summit &#8211; West\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\",\"name\":\"Imperial Clinical Research Services Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/b51d07a38b5a99e1182dd1918173a2da\",\"name\":\"Dan McDonald\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g\",\"caption\":\"Dan McDonald\"},\"description\":\"Dan is vice president, business development, Imperial Clinical Research Services. Dan is a seasoned executive who specializes in identifying income opportunities, building strategic partnerships, and managing contract negotiations. A prolific and popular thought leader, Dan has presented at numerous industry conferences and events, has conducted workshops and sessions on patient engagement, and has been published numerous times in industry books, trade magazines, and journals.\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/author\\\/dmcdonald\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Talking Recruitment with CMOs","description":"current trends in patient recruitment impacting CMOs and how these individuals are addressing the challenge of ontime enrollment in their clinical trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/","og_locale":"en_US","og_type":"article","og_title":"Talking Recruitment with CMOs","og_description":"current trends in patient recruitment impacting CMOs and how these individuals are addressing the challenge of ontime enrollment in their clinical trials.","og_url":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/","og_site_name":"Imperial Clinical Research Services Blog","article_published_time":"2015-11-12T16:43:31+00:00","article_modified_time":"2023-12-14T15:01:19+00:00","og_image":[{"width":800,"height":533,"url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/11\/Current-trends-in-patient-recruitment.jpg","type":"image\/jpeg"}],"author":"Dan McDonald","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dan McDonald","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/#article","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/"},"author":{"name":"Dan McDonald","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/b51d07a38b5a99e1182dd1918173a2da"},"headline":"Talking Recruitment with Small\/Mid BioPharm CMOs at CMO Summit &#8211; West","datePublished":"2015-11-12T16:43:31+00:00","dateModified":"2023-12-14T15:01:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/"},"wordCount":351,"commentCount":0,"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/11\/Current-trends-in-patient-recruitment.jpg","keywords":["Biopharmaceutical Recruitment Strategies","Clinical Development Insights","Clinical Operations Challenges","Clinical Research Management","Clinical Trial CMO Summit","CMO Summit Discussions","Drug Development Planning","Midsize BioPharma CMOs","Patient Recruitment Solutions","Small Biopharmaceutical Companies"],"articleSection":["Life-Science Events","Patient Recruitment and Retention"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/","url":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/","name":"Talking Recruitment with CMOs","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/#primaryimage"},"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/11\/Current-trends-in-patient-recruitment.jpg","datePublished":"2015-11-12T16:43:31+00:00","dateModified":"2023-12-14T15:01:19+00:00","author":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/b51d07a38b5a99e1182dd1918173a2da"},"description":"current trends in patient recruitment impacting CMOs and how these individuals are addressing the challenge of ontime enrollment in their clinical trials.","breadcrumb":{"@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/#primaryimage","url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/11\/Current-trends-in-patient-recruitment.jpg","contentUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2015\/11\/Current-trends-in-patient-recruitment.jpg","width":800,"height":533},{"@type":"BreadcrumbList","@id":"https:\/\/www.imperialcrs.com\/blog\/patient-recruitment-and-retention\/talking-recruitment-with-smallmid-biopharm-cmos-at-cmo-summit-west\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.imperialcrs.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Talking Recruitment with Small\/Mid BioPharm CMOs at CMO Summit &#8211; West"}]},{"@type":"WebSite","@id":"https:\/\/www.imperialcrs.com\/blog\/#website","url":"https:\/\/www.imperialcrs.com\/blog\/","name":"Imperial Clinical Research Services Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.imperialcrs.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/b51d07a38b5a99e1182dd1918173a2da","name":"Dan McDonald","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/eadd7098b6c648f3acace4396c5f20b27a640b101214df774c63a5078311f706?s=96&d=mm&r=g","caption":"Dan McDonald"},"description":"Dan is vice president, business development, Imperial Clinical Research Services. Dan is a seasoned executive who specializes in identifying income opportunities, building strategic partnerships, and managing contract negotiations. A prolific and popular thought leader, Dan has presented at numerous industry conferences and events, has conducted workshops and sessions on patient engagement, and has been published numerous times in industry books, trade magazines, and journals.","url":"https:\/\/www.imperialcrs.com\/blog\/author\/dmcdonald\/"}]}},"_links":{"self":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/1387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/comments?post=1387"}],"version-history":[{"count":1,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/1387\/revisions"}],"predecessor-version":[{"id":69325,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/1387\/revisions\/69325"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media\/69665"}],"wp:attachment":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media?parent=1387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/categories?post=1387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/tags?post=1387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}